
Russia says its second Covid vaccine is 100% effective post clinical trials
The immunological efficacy of the Russia-developed coronavirus vaccine EpiVacCorona is 100 per cent, the Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being said on Tuesday.
- Region:
- World
- Category:
- Technology